IP Library › Assignment 073966/0761
Patent Assignment
Reel/Frame 073966/0761

Assignment of Assignor's Interest

Recorded: 2025-12-18 Pages: 9
Assignor
SANEGENE BIO INC.
Executed: 2025-12-17
Assignee
SANEGENE BIO USA INC.
300 TRADECENTER DRIVE, SUITE 5500, WOBURN, MASSACHUSETTS, 01801
Covered Properties (52)
1'-Alkyl Modified Ribose Derivatives and Methods of Use
Application: 63/229,628 →
1'-Alkyl Modified Ribose Derivatives and Methods of Use
Application: 19/282,328 →
2'-Alkyl or 3'- Alkyl Modified Ribose Derivatives and Methods of Use
Application: 63/246,870 →
2'-Alkyl or 3'- Alkyl Modified Ribose Derivatives and Methods of Use
Application: 17/950,520 →
Publication: US 2023/0241224
Polyhydroxylated Cyclopentane Derivatives and Methods of Use
Application: 63/252,358 →
Polyhydroxylated Cyclopentane Derivatives and Methods of Use
Application: 17/960,202 →
Publication: US 2023/0227480
5'-Modified Carbocyclic Ribonucleotide Derivatives and Methods of Use
Application: 63/312,554 →
5'-Modified Carbocyclic Ribonucleotide Derivatives and Methods of Use
Application: 18/172,719 →
Publication: US 2023/0346819
Optimized 2'- Modified Ribose Derivatives and Methods of Use
Application: 63/359,969 →
Optimized 2'- Modified Ribose Derivatives and Methods of Use
Application: 18/350,256 →
Publication: US 2024/0218363
Double Stranded Rna Targeting Proprotein Convertase Subtilisin Kexin 9 (PCSK9) and Methods of Use Thereof
Application: 18/750,463 →
Publication: US 2025/0027089
Double Stranded Rna Targeting Angiopoietin-Like 3 (Angptl-3) and Methods of Use Thereof
Application: 63/281,253 →
Double Stranded Rna Targeting Angiopoietin-Like 3 (Angptl-3) and Methods of Use Thereof
Application: 18/057,186 →
Publication: US 2023/0159930
Double Stranded Rna Targeting Angiopoietin-Like 3 (Angptl-3) and Methods of Use Thereof
Application: 18/757,656 →
Publication: US 2025/0059540
Double Stranded Rna Targeting Angiotensinogen (Agt) and Methods of Use Thereof
Application: 63/395,445 →
Double Stranded Rna Targeting Angiotensinogen (Agt) and Methods of Use Thereof
Application: 18/366,574 →
Publication: US 2024/0052348
Double Stranded Rna Targeting 17-Beta Hydroxysteroiddehydrogenase 13 (HSD17B13) and Methods of Use Thereof
Application: 63/339,750 →
Double Stranded Rna Targeting 17-Beta Hydroxysteroiddehydrogenase 13 (HSD17B13) and Methods of Use Thereof
Application: 18/314,103 →
Publication: US 2024/0002857
Nucleotide-Based Enhancement Agent for Rna Delivery and Therapy
Application: 63/421,799 →
Nucleotide-Based Enhancement Agent for Rna Delivery and Therapy
Application: 19/119,936 →
Lipid-Based Enhancement Agent for Rna Delivery and Therapy
Application: 63/515,256 →
Lipid-Based Enhancement Agent for Rna Delivery and Therapy
Application: 18/782,288 →
Publication: US 2025/0064939
Small Interfering Rna Targeting Hbv and Uses Thereof
Application: 18/585,697 →
Publication: US 2024/0309383
Small Interfering Rna Targeting APOC3 and Uses Thereof
Application: 18/593,706 →
Publication: US 2024/0309380
Small Interfering Rna Targeting C3 and Uses Thereof
Application: 63/416,070 →
Small Interfering Rna Targeting C3 and Uses Thereof
Application: 18/487,663 →
Publication: US 2024/0175026
Small Interfering Rna Targeting C3 and Uses Thereof
Application: 18/650,710 →
Publication: US 2024/0301421
Small Interfering Rna Targeting Cfb and Uses Thereof
Application: 63/433,735 →
Small Interfering Rna Targeting Cfb and Uses Thereof
Application: 18/653,253 →
Publication: US 2024/0294916
Lipid-Based Conjugates for Central Nervous System, Peripheral Nervous System, and Ocular Delivery
Application: 63/499,944 →
Lipid-Based Conjugates for Systemic, Central Nervous System, Peripheral Nervous System, and Ocular Delivery
Application: 18/654,816 →
Publication: US 2025/0018045
Title Not Available
Application: 63/677,559 →
Small Interfering Rna Targeting Cfb and Uses Thereof
Application: 63/661,546 →
Small Interfering Rna Targeting Cfb and Uses Thereof
Application: 19/240,198 →
1'-Alkyl Modified Ribose Derivatives and Methods of Use
Application: 17/881,935 →
Publication: US 2023/0138928
2'- Alkyl or 3'-Alkyl Modified Ribose Derivatives and Methods of Use
Polyhydroxylated Cyclopentane Derivatives and Methods of Use
5'-Modified Carbocyclic Ribonucleotide Derivatives and Methods of Use
Optimized 2’- Modified Ribose Derivatives and Methods of Use
Double Stranded Rna Targeting Proprotein Convertase Subtilisin Kexin 9 (PCSK9) and Methods of Use Thereof
Double Stranded Rna Targeting Angiopoietin-Like 3 (Angptl-3) and Methods of Use Thereof
Double Stranded Rna Targeting Angiotensinogen (Agt) and Methods of Use Thereof
Double Stranded Rna Targeting 17-Beta Hydroxysteroiddehydrogenase 13 (HSD17B13) and Methods of Use Thereof
Nucleotide-Based Enhancement Agent for Rna Delivery and Therapy
Lipid-Based Enhancement Agent for Rna Delivery and Therapy
Small Interfering Rna Targeting APOC3 and Uses Thereof
Small Interfering Rna Targeting C3 and Uses Thereof
Small Interfering Rna Targeting Cfb and Uses Thereof
Lipid-Based Conjugates for Systemic, Central Nervous System, Peripheral Nervous System, and Ocular Delivery
Small Interfering Rna Targeting Lp(a) and Uses Thereof
Saccharide-Based Conjugates for Rna Delivery and Therapy
Small Interfering Rna Targeting Cfb and Uses Thereof
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 18, 2021
From: WANG, WEIMIN; CAI, XIAOCHUAN
To: SANEGENE BIO USA, INC.
Reel/Frame 057215/0651 →
Assignment of Assignor's Interest May 13, 2022
From: WANG, WEIMIN; CAI, XIAOCHUAN
To: SANEGENE BIO USA INC.
Reel/Frame 059900/0223 →
Assignment of Assignor's Interest May 13, 2022
From: WANG, WEIMIN; CAI, XIAOCHUAN
To: SANEGENE BIO USA INC.
Reel/Frame 059900/0018 →
Assignment of Assignor's Interest May 13, 2022
From: ZHANG, CHUNYANG; WANG, SHIYU; CAI, XIAOCHUAN; WANG, WEIMIN
To: SANEGENE BIO USA INC.
Reel/Frame 059900/0184 →
Assignment of Assignor's Interest May 13, 2022
From: WANG, WEIMIN; CAI, XIAOCHUAN
To: SANEGENE BIO USA INC.
Reel/Frame 059900/0209 →
Assignment of Assignor's Interest Jul 22, 2022
From: WANG, WEIMIN; CAI, XIAOCHUAN
To: SANEGENE BIO USA INC.
Reel/Frame 060592/0137 →
Assignment of Assignor's Interest Jul 27, 2022
From: WANG, WEIMIN; CAI, XIAOCHUAN; WANG, SHIYU
To: SANEGENE BIO USA INC.
Reel/Frame 060639/0734 →
Assignment of Assignor's Interest Jul 27, 2022
From: ZHANG, CHUNYANG; YANG, ZHONGFA; WANG, SHIYU; WANG, WEIMIN
To: SANEGENE BIO USA INC.
Reel/Frame 060639/0541 →
Assignment of Assignor's Interest Oct 7, 2022
From: ZHANG, CHUNYANG; YANG, ZHONGFA; WANG, SHIYU; WANG, WEIMIN
To: SANEGENE BIO USA INC.
Reel/Frame 061342/0515 →
Assignment of Assignor's Interest Nov 28, 2022
From: ZHANG, CHUNYANG; YANG, ZHONGFA; GENG, XIN; WANG, SHIYU
To: SANEGENE BIO USA INC.
Reel/Frame 061892/0459 →
Assignment of Assignor's Interest Nov 30, 2022
From: WANG, WEIMIN; CAI, XIAOCHUAN
To: SANEGENE BIO USA INC.
Reel/Frame 061918/0691 →
Assignment of Assignor's Interest Dec 1, 2022
From: WANG, WEIMIN; CAI, XIAOCHUAN; WANG, SHIYU; ZHANG, CHUNYANG
To: SANEGENE BIO USA INC.
Reel/Frame 061937/0365 →
Assignment of Assignor's Interest Dec 9, 2022
From: WANG, WEIMIN; CAI, XIAOCHUAN
To: SANEGENE BIO USA INC.
Reel/Frame 062042/0750 →
Assignment of Assignor's Interest Jan 26, 2023
From: ZHANG, CHUNYANG; WANG, SHIYU; CAI, XIAOCHUAN; WANG, WEIMIN
To: SANEGENE BIO USA INC.
Reel/Frame 062498/0733 →
Assignment of Assignor's Interest Jan 26, 2023
From: ZHANG, CHUNYANG; YANG, ZHONGFA; GENG, XIN; WANG, SHIYU
To: SANEGENE BIO USA INC.
Reel/Frame 062498/0988 →
Assignment of Assignor's Interest Jan 26, 2023
From: ZHANG, CHUNYANG; YANG, ZHONGFA; GENG, XIN; WANG, SHIYU
To: SANEGENE BIO USA INC.
Reel/Frame 062499/0235 →
Assignment of Assignor's Interest Jun 13, 2023
From: WANG, WEIMIN; CAI, XIAOCHUAN
To: SANEGENE BIO USA INC.
Reel/Frame 063928/0587 →
Assignment of Assignor's Interest Jul 11, 2023
From: WANG, WEIMIN; CAI, XIAOCHUAN; JIANG, JUN; BELOV, DMITRII
To: SANEGENE BIO USA INC.
Reel/Frame 064206/0779 →
Assignment of Assignor's Interest Jul 27, 2023
From: WANG, WEIMIN; CAI, XIAOCHUAN; WANG, SHIYU
To: SANEGENE BIO USA INC.
Reel/Frame 064406/0842 →
Assignment of Assignor's Interest Jul 27, 2023
From: ZHANG, CHUNYANG; YANG, ZHONGFA; WANG, SHIYU; WANG, WEIMIN
To: SANEGENE BIO USA INC.
Reel/Frame 064410/0502 →
Assignment of Assignor's Interest Oct 20, 2023
From: WANG, WEIMIN; CAI, XIAOCHUAN; JIANG, JUN; WANG, SHIYU
To: SANEGENE BIO USA INC.
Reel/Frame 065297/0788 →
Assignment of Assignor's Interest Nov 1, 2023
From: ZHANG, CHUNYANG; GENG, XIN; WANG, SHIYU; WANG, WEIMIN
To: SANEGENE BIO USA INC.
Reel/Frame 065424/0165 →
Assignment of Assignor's Interest Nov 9, 2023
From: ZHANG, CHUNYANG; YANG, ZHONGFA; WANG, SHIYU; WANG, WEIMIN
To: SANEGENE BIO USA INC.
Reel/Frame 065513/0029 →
Assignment of Assignor's Interest May 1, 2024
From: ZHANG, CHUNYANG; GENG, XIN; WANG, SHIYU; WANG, WEIMIN
To: SANEGENE BIO USA INC.
Reel/Frame 067279/0112 →
Assignment of Assignor's Interest May 24, 2024
From: ZHANG, CHUNYANG; GENG, XIN; WANG, SHIYU; WANG, WEIMIN
To: SANEGENE BIO USA INC.
Reel/Frame 067523/0921 →